FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D065100:CCR5 Receptor Antagonists; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists